Pulmonale Hypertonie: was ist neu in der Therapie?

Pulmonary hypertension (PH) comprises a group of pulmonary vascular diseases that are characterized by progressive exertional dyspnea and right heart insufficiency ultimately resulting in right heart decompensation. The classification is into five clinical subgroups that form the absolutely essentia...

Full description

Saved in:
Bibliographic Details
Main Authors: Sommer, Natascha (Author) , Weigand, Markus A. (Author)
Format: Article (Journal)
Language:German
English
Published: 4. August 2016
In: Der Anaesthesist
Year: 2016, Volume: 65, Issue: 8, Pages: 635-652
ISSN:1432-055X
DOI:10.1007/s00101-016-0207-y
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00101-016-0207-y
Verlag, Volltext: https://doi.org/10.1007/s00101-016-0207-y
Get full text
Author Notes:N. Sommer, M. Hecker, K. Tello, M. Richter, C. Liebetrau, M.A. Weigand, W. Seeger, A. Ghofrani, H. Gall
Description
Summary:Pulmonary hypertension (PH) comprises a group of pulmonary vascular diseases that are characterized by progressive exertional dyspnea and right heart insufficiency ultimately resulting in right heart decompensation. The classification is into five clinical subgroups that form the absolutely essential basis for decisions on the indications for different pharmacological and non-pharmacological forms of treatment. The guidelines were updated in 2015 and in addition to the hitherto existing pharmacological treatment options of phosphodiesterase type 5 inhibitors, endothelin receptor antagonists and prostacyclins, the soluble guanylate cyclase stimulator riociguat has now been incorporated for treatment of certain forms of PH. This article provides an overview of the new treatment recommendations in the current guidelines, e. g. for PH patients who are in intensive care units due to surgical interventions or progressive right heart insufficiency.
Item Description:Paralleltitel von der Frontdoor übernommen
Mit engl. Zusammenfassung
Gesehen am 16.10.2018
Physical Description:Online Resource
ISSN:1432-055X
DOI:10.1007/s00101-016-0207-y